Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Burnand, Y.
* Articles by Rosset, N.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Burnand, Y.
* Articles by Rosset, N.
Related Collections
* Depression
* Psychodynamic Therapy
* Antidepressants
Psychiatr Serv 53:585-590, May 2002
© 2002 American Psychiatric Association


Other Articles

Psychodynamic Psychotherapy and Clomipramine in the Treatment of Major Depression

Yvonne Burnand, Ph.D., Antonio Andreoli, M.D., Evelyne Kolatte, M.D., Aurora Venturini, M.D. and Nicole Rosset, Ph.D.

OBJECTIVE: The authors compared a combination of clomipramine and psychodynamic psychotherapy with clomipramine alone in a randomized controlled trial among patients with major depression. METHODS: Seventy-four patients between the ages of 20 and 65 years who were assigned to ten weeks of acute outpatient treatment for major depression were studied. Bipolar disorder, psychotic symptoms, severe substance dependence, organic disorder, past intolerance to clomipramine, and mental retardation were exclusion criteria. RESULTS: Marked improvement was noted in both treatment groups. Combined treatment was associated with less treatment failure and better work adjustment at ten weeks and with better global functioning and lower hospitalization rates at discharge. A cost savings of $2,311 per patient in the combined treatment group, associated with lower rates of hospitalization and fewer lost work days, exceeded the expenditures related to providing psychotherapy. CONCLUSIONS: Provision of supplemental psychodynamic psychotherapy to patients with major depression who are receiving antidepressant medication is cost-effective.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
F. Leichsenring, S. Rabung, and E. Leibing
The Efficacy of Short-term Psychodynamic Psychotherapy in Specific Psychiatric Disorders: A Meta-analysis
Arch Gen Psychiatry, December 1, 2004; 61(12): 1208 - 1216.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
S. Pampallona, P. Bollini, G. Tibaldi, B. Kupelnick, and C. Munizza
Combined Pharmacotherapy and Psychological Treatment for Depression: A Systematic Review
Arch Gen Psychiatry, July 1, 2004; 61(7): 714 - 719.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
D. Gelyana and D. Garfield
The Neuroscience of Psychotherapy: Building and Rebuilding the Human Brain
Psychiatr Serv, October 1, 2003; 54(10): 1419 - 1420.
[Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
T. L. Mark and R. M. Coffey
What Drove Private Health Insurance Spending On Mental Health And Substance Abuse Care, 1992-1999?
Health Aff., January 1, 2003; 22(1): 165 - 172.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org